HempFusion Announces Launch of Terpene-Infused Full Spectrum CBD Topicals
September 10th, 2019
DENVER, Sept. 10, 2019 /CNW/ – HempFusion®, a leading Hemp/CBD Company in the United States with distribution of its family of brands to over 3,400 retailers across 47 states, is pleased to announce the launch of its new line of all-natural topical formulations. HempFusion’s terpene-infused, full-spectrum CBD topicals feature plant-based terpenes infused with HempFusion’s unique full-spectrum hemp CBD extract that can be applied directly to the skin for quick and easy support.
“Our product development team led by naturopathic doctor and Company President, Jason Mitchell N.D., continues to create best in class full-spectrum CBD products and we look forward to releasing more SKU’s focused on consumer needs in the coming months,” Stated Ian deQueiroz, Co-founder and CEO of HempFusion®. “Additional products not only benefit consumers but also help the Company expand its potential retail distribution channels with big box grocery stores, pharmacies and national and independent retailers,” continued deQuieroz.
Currently available in a Hemp Extract CBD Balm and Hemp Extract CBD Cream, HempFusion’s terpene-infused topicals offer soothing topical support that works by interacting with the human Endocannabinoid System (ECS) in a non-intoxicating capacity. While CBD content is important, HempFusion’s nutrient-dense topical products are crafted with high-quality whole hemp nutrients that are far beyond CBD alone. For instance, HempFusion® topicals feature plant-based terpenes like ß-caryophyllene, and other key ingredients for topical support, like soothing Menthol from Mint, as well as MSM and Magnesium Oil.
“Topical creams and lotions are emerging as the most popular CBD offerings on the market. HempFusion combines the highest quality sources of phytocompounds manufactured under the strictest cGMP standards to achieve maximum efficacy and safety,” said Jason Mitchell, Co-Founder and President of HempFusion®. He adds “HempFusion® stands alone when it comes to the added benefits of terpenes in all of our products. We are excited to offer consumers new and innovative products across a variety of delivery methods.”
HempFusion® is now targeting over 26,000 new stores, including conventional grocers, drug and convenience stores, vitamin and fitness shops, and doctor and practitioner networks. With 14% of American’s stating they use CBD according to Gallup Inc. and industry-leading financing in place, HempFusion® continues to expand its product portfolio, distribution channels and increase brand awareness to become a leader in the global CBD market.
HempFusion’s complete product offering, additional information and store locator can be accessed by visiting www.hempfusion.com.
HempFusion is a premium hemp-based cannabidiol (“CBD”) wellness Company with distribution of its family of brands to over 3,400 retailers across 47 US states. The Company is engaged in the advancement of therapeutic benefits of industrial hemp extract while maintaining the highest level of compliance in the industry. HempFusion’s wide variety of 25+ full spectrum CBD products are sourced from only the highest quality phytocompounds manufactured under the strictest cGMP standards to achieve maximum efficacy and safety. HempFusion’s primary focus is formulating and marketing premium consumer-specific product lines with various delivery methods, across multiple distribution platforms. The Company’s products are based on a proprietary Whole Food Hemp Complex ™ and are available through independently owned and national chain health food stores, or by visiting www.hempfusion.com.
This news release contains forward-looking information, which involves known and unknown risks, uncertainties, and other factors that may cause actual events to differ materially from current expectation. Important factors — including the availability of funds, the results of financing efforts and the parties’ due diligence reviews, and general market conditions — that could cause actual results to differ materially from the Company’s expectations. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
SOURCE Hemp Fusion
For further information: Investor Relations: Name: Spencer MacLean, Email: [email protected], Phone: 416-803-5638, Web: www.hempfusion.com
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
Follow Us on Social Media
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.